Exscientia plc (EXAI)
NASDAQ: EXAI · Real-Time Price · USD
4.840
+0.150 (3.20%)
Nov 19, 2024, 4:00 PM EST - Market closed
Exscientia Market Cap
Exscientia has a market cap or net worth of $633.50 million as of November 21, 2024. Its market cap has decreased by -8.13% in one year.
Market Cap
633.50M
Enterprise Value
331.25M
1-Year Change
-8.13%
Ranking
Category
Stock Price
$4.84
Market Cap Chart
Since the IPO on October 1, 2021, Exscientia's market cap has decreased from $2.61B to $633.50M, a decrease of -75.73%. That is a compound annual growth rate of -36.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 633.50M | -20.90% |
| Dec 29, 2023 | 800.86M | 22.28% |
| Dec 30, 2022 | 654.94M | -72.47% |
| Dec 31, 2021 | 2.38B | -8.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anavex Life Sciences | 631.73M |
| Stoke Therapeutics | 629.25M |
| Tourmaline Bio | 628.76M |
| Entrada Therapeutics | 617.82M |
| Oculis Holding AG | 613.24M |
| Phathom Pharmaceuticals | 607.87M |
| ORIC Pharmaceuticals | 604.05M |
| EyePoint Pharmaceuticals | 601.97M |